The role of neuroinflammation and neurovascular dysfunction in major depressive disorder
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Although depression has generally been explained with monoamine theory, it is far more multifactorial, and therapies that address the disease's pathway have not been developed. In this context, an understanding of neuroinflammation and neurovascular dysfunction would enable a more comprehensive approach to depression. Inflammation is in a sense a type of allostatic load involving the immune, endocrine, and nervous systems. Neuroinflammation is involved in the pathophysiology of depression by increasing proinflammatory cytokines, activating the hypothalamus-pituitary-adrenal axis, increasing glucocorticoid resistance, and affecting serotonin synthesis and metabolism, neuronal apoptosis and neurogenesis, and neuroplasticity. In future, identifying the subtypes of depression with increased vulnerability to inflammation and testing the effects of inflammatory modulating agents in these patient groups through clinical trials will lead to more concrete conclusions on the matter. The vascular depression hypothesis is supported by evidence for the association between vascular disease and late-onset depression and between ischemic brain lesions and distinctive depressive symptoms. Vascular depression may be the entity most suitable for studies of the mechanisms of depression. Pharmacotherapies used in the prevention and treatment of cerebrovascular disease may help prevent vascular depression. In future, developments in structural and functional imaging, electrophysiology, chronobiology, and genetics will reveal the association between depression and brain lesions. This article aims to give a general review of the existing issues examined in the literature pertaining to depression-related neuroinflammatory and vascular functions, related pathophysiology, applicability to depression treatment, and directions for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
'Vascular Depression' Hypothesis
Alexopoulos, G. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220033006 · Cited by 1,843 · cited 2×
“Silent cerebral ischemia and white-matter hyperintensity (WMH) are more commonly observed in late-onset depression, and evidence suggests that depressive symptoms are related to the collapse of corticostriatopallidothalamocortical circuits.(3,4) Such a view of neuroinflammation or neurovascular function in depression…”
Gut feelings: the emerging biology of gut-brain communication
Mayer, E. A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3071 · Cited by 1,726 · cited 1×
“Gut microbiota have bidirectional interactions with the CNS and immune system, and involve the immune (cytokines), endocrine (HPA axis), autonomic nervous system, and enteric nervous system forming the microbiota–gut–brain axis.(59) Neuroactive substances derived from the intestinal lumen can penetrate the gut mucosa.”
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Chollet, F., Tardy, J., Albucher, J.-F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70314-8 · Cited by 925 · cited 2×
“135,136 Further research is needed to examine the effects of each antidepressant on the recovery of neurologic deficits in poststroke depression.”
Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress
Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862 · cited 1×
“In a recent study, inhibiting IL1β activity prevented neurogenesis suppression caused by stress.(47) Meanwhile, administration”
Pace, T. W. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, A. H., & Heim, C. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1630 · Cited by 810
Brain inflammation and adult neurogenesis: The dual role of microglia
Ekdahl, C. T., Kokaia, Z., & Lindvall, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.052 · Cited by 801
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728
Cytokine-induced sickness behavior
Kelley, K. W., Bluthé, R.-M., Dantzer, R., Zhou, J.-H., Shen, W.-H., Johnson, R. W., & Broussard, S. R. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00077-6 · Cited by 716
Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects
Mahar, I., Bambico, F. R., Mechawar, N., & Nobrega, J. N. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.009 · Cited by 694 · cited 3×
“44 Although it may not be the main cause of depression or an essential factor contributing to the onset of depression, neurogenesis may be a necessary component of effective antidepression therapy.”
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Kim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620 · cited 4×
“that successive antidepression therapy would strengthen neurogenesis.(26) Findings that support this theory suggest”
InfluentialSelf-citationPetra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., & Theoharides, T. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.002 · Cited by 592
Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.005 · Cited by 578
Adult hippocampal neurogenesis is involved in anxiety-related behaviors
Revest, J.-M., Dupret, D., Koehl, M., Funk-Reiter, C., Grosjean, N., Piazza, P.-V., & Abrous, D. N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.15 · Cited by 549
Depression and Hippocampal Neurogenesis: A Road to Remission?
Eisch, A. J., & Petrik, D. (2012) · Science · doi:10.1126/science.1222941 · Cited by 516 · cited 3×
“43,44 Chronic stress activates microglia in the brain, and cytokines released by microglia affect neurogenesis.”
White matter hyperintensities in late life depression: a systematic review
Herrmann, L. L., Le Masurier, M., & Ebmeier, K. P. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.124651 · Cited by 456
Cerebral White Matter Lesions and Depressive Symptoms in Elderly Adults
de Groot, J. C., de Leeuw, F.-E., Oudkerk, M., Hofman, A., Jolles, J., & Breteler, M. M. B. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1071 · Cited by 438
Cattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K. J., Craig, I. W., Anacker, C., Zunsztain, P. A., McGuffin, P., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.191 · Cited by 436
Boone, K. B. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290141024 · Cited by 400 · cited 1×
“108 Such cognitive dysfunction was also evident in patients with late-onset depression with vascular risk factors, and these findings support the threshold theory as a mechanism of vascular depression.”
Hickie, I., Scott, E., Mitchell, P., Wilhelm, K., Austin, M.-P., & Bennett, B. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00174-2 · Cited by 398
Tuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Alesci, S., Martinez, P. E., Kelkar, S., Ilias, I., Ronsaville, D. S., Listwak, S. J., Ayala, A. R., Licinio, J., Gold, H. K., Kling, M. A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1667 · Cited by 372
Cytokines, stress and depressive illness: Brain-immune interactions.
Anisman, H., & Merali, Z. (2003) · Annals of Medicine · doi:10.1080/07853890310004075 · Cited by 302
Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta‐Soares, G. B., Frey, B. N., Bowden, C. L., & Soares, J. C. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.912 · Cited by 298
Wong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295
Warner-Schmidt, J. L., Vanover, K. E., Chen, E. Y., Marshall, J. J., & Greengard, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104836108 · Cited by 291
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.015 · Cited by 290
Inflammation, Glutamate, and Glia in Depression:A Literature Review
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289 · cited 1×
“81 During this process, riluzole and ketamine prevent neurotoxicity and reduce inflammation by inhibiting glutamate secretion and NMDA receptors.”
Bae, J. N., MacFall, J. R., Krishnan, K. R. R., Payne, M. E., Steffens, D. C., & Taylor, W. D. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.052 · Cited by 288 · cited 1×
“119 Furthermore, one report suggested that patients with late-onset depression had low FA in the right superior frontal gyrus, implying that minimal changes in the white matter of the frontal lobe are related to the onset of depression.”
Savitz, J., Drevets, W. C., Smith, C. M., Victor, T. A., Wurfel, B. E., Bellgowan, P. S., Bodurka, J., Teague, T. K., & Dantzer, R. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.194 · Cited by 272
Sex differences in psychopathology: of gonads, adrenals and mental illness
Solomon, M. B., & Herman, J. P. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.033 · Cited by 272 · cited 1×
“Neuroinflammation, gonadal hormones, and gut–brain axis Mounting evidence suggests that women are more susceptible to stress-induced depression than males.(52) Stress can disrupt activation of both the HPA and hypothalamic–pituitary– gonadal axes, both of which modulate neuroinflammatory pathways and brain regions inv…”
Jeon, S. W., & Kim, Y. K. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i3.283 · Cited by 247
Self-citationA psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240 · cited 1×
“80 Studies have also shed light on the anti-inflammatory effects of riluzole and ketamine, which are glutamatergic modulators.”
Taylor, W. D., MacFall, J. R., Payne, M. E., McQuoid, D. R., Provenzale, J. M., Steffens, D. C., & Krishnan, K. R. R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1293 · Cited by 230 · cited 1×
“120 Some have argued that atherosclerosis increases the concentration of inflammatory markers in the blood caused by cerebral ischemia, which in turn stimulates the central monoamine system, inducing neurotoxicity in the monoamine system and ultimately causing depression.”
Réus, G. Z., Jansen, K., Titus, S., Carvalho, A. F., Gabbay, V., & Quevedo, J. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.05.007 · Cited by 221
Pollak, Y., & Yirmiya, R. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003152 · Cited by 215 · cited 1×
“Moreover, studies consistently report that autoimmune diseases, such as rheumatoid arthritis and myelosclerosis, and chronic inflammation diseases, such as cancer, are associated with depression.(30) Study findings that administration of cytokine antagonists improves depressive symptoms in depressed”
Davies, N. M., Kehoe, P. G., Ben-Shlomo, Y., & Martin, R. M. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110347 · Cited by 212 · cited 4×
“to be effective in cardiovascular diseases but also to have anti-inflammatory effects in the CNS.(77) Once their specific”
InfluentialTreatment of Vascular Depression Using Repetitive Transcranial Magnetic Stimulation
Jorge, R. E., Moser, D. J., Acion, L., & Robinson, R. G. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.45 · Cited by 211 · cited 1×
“130 Furthermore, augmenting antidepressants with calcium-channel blockers for treating vascular depression was effective in reducing depressive symptoms and lowering recurrence rates.”
Cytokines, “depression due to a general medical condition”, and antidepressant drugs
Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., Barak, O., Reichenberg, A., Cohen, E., Shavit, Y., et al. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_16 · Cited by 208 · cited 1×
“31,32 Third, regarding the relationship between cytokine-related treatment and depression, at least 25%–50% of patients who are administered IFN α , which is used for patients with such viral infections as hepatitis C or cancer patients, develop depression.”
Alexopoulos, G. S., Raue, P. J., Kiosses, D. N., Mackin, R. S., Kanellopoulos, D., McCulloch, C., & Areán, P. A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.177 · Cited by 199
Barrientos, R. M., Sprunger, D. B., Campeau, S., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.06.009 · Cited by 192 · cited 1×
“Brain-derived neurotrophic factor ultimately affects sickness behavior through the growth and development of neurons and synaptic plasticity, and stress-induced IL1 decreases the expression of this protein.(23,24) Many clinical and experimental studies have proposed the hypothesis that cytokines play an important role…”
Song, C., Merali, Z., & Anisman, H. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00271-1 · Cited by 172
TNF-α as a molecular target in bipolar disorder
Brietzke, E., & Kapczinski, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.01.006 · Cited by 163
Kaneko, N., Kudo, K., Mabuchi, T., Takemoto, K., Fujimaki, K., Wati, H., Iguchi, H., Tezuka, H., & Kanba, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301137 · Cited by 152 · cited 1×
“46 In a recent study, inhibiting IL1 β activity prevented neurogenesis suppression caused by stress.”
Capuron, L., Ravaud, A., & Dantzer, R. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200105000-00007 · Cited by 148 · cited 2×
“Animal studies have also demonstrated that cytokine injection inhibits memory function by affecting the hippocampus.(42)”
Lin, P.-Y., Mischoulon, D., Freeman, M. P., Matsuoka, Y., Hibbeln, J., Belmaker, R. H., & Su, K.-P. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.111 · Cited by 145
Wang, X., Wu, H., & Miller, A. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001339 · Cited by 128 · cited 1×
“previous report suggested that immune cells are not affected by glucocorticoids in depression and chronic stress, because the activation of cytokine pathways, such as p38 MAPK, hinders glucocorticoid signaling.(18,19) In other words, cytokines inhibit the negative-feedback regulation of the HPA axis, maintaining hyper…”
Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Part 2: Study Outcomes
Howland, R. H. (2008) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20081001-05 · Cited by 115 · cited 1×
“73,74 However, these results have been rebutted by follow-up studies.”
Paulus, M. P., Feinstein, J. S., Simmons, A., & Stein, M. B. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.023 · Cited by 115 · cited 1×
“Elevated dACC activity increases the risk of affective and anxiety disorders, and it has been confirmed that an IFNα injection increases local blood flow to the dACC on functional magnetic resonance imaging (MRI).(41) Furthermore, a study using (18)F positron-emission tomography (PET) reported that IFNα injection affe…”
Depressed gut? The microbiota-diet-inflammation trialogue in depression
Koopman, M., & El Aidy, S. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000350 · Cited by 114 · cited 1×
“61,62”
Taragano, F. E., Allegri, R., Vicario, A., Bagnatti, P., & Lyketsos, C. G. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.340 · Cited by 103 · cited 1×
“One study found that using nimodipine, a calcium-channel blocker, with antidepressants for patients with vascular depression improved depression more quickly with lower recurrence and a higher complete remission rate.(140) Other researchers have suggested that antihypertensive drugs themselves should be used with caut…”
Taragano, F. E., Bagnatti, P., & Allegri, R. F. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205001493 · Cited by 90
Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?
Thompson, A., Boekhoorn, K., Van Dam, A. ‐., & Lucassen, P. J. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00379.x · Cited by 73
Ried, L. D., Tueth, M. J., Handberg, E., Kupfer, S., & Pepine, C. J. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000160468.69451.7f · Cited by 63 · cited 1×
“In one study, verapamil showed a significant improvement in depressive symptoms, but atenolol did not.(143)”
Chronic hepatitis C virus infection and depression
Adinolfi, L. E., Nevola, R., Rinaldi, L., Romano, C., & Giordano, M. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.03.007 · Cited by 59
Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats
Wang, Y., Yang, F., Liu, Y.-F., Gao, F., & Jiang, W. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.035 · Cited by 56
Brain cytokines and neuropsychiatric disorders
Theoharides, T. C., Weinkauf, C., & Conti, P. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000148026.86483.4f · Cited by 56
Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder
Uher, R., Carver, S., Power, R. A., Mors, O., Maier, W., Rietschel, M., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291712000190 · Cited by 45 · cited 1×
“However, these results have been rebutted by follow-up studies.(75) Such inconsistency in results should be addressed by establishing a standard for inflammation markers for depression and identifying the subtypes of depression for which AIDs have benefits.”
Cited by
Ali, T., Rahman, S. U., Hao, Q., Li, W., Liu, Z., Ali Shah, F., Murtaza, I., Zhang, Z., Yang, X., Liu, G., et al. (2020) · Journal of Pineal Research · doi:10.1111/jpi.12667 · Cited by 325
Therapeutic Properties and Pharmacological Activities of Asiaticoside and Madecassoside: A Review
Bandopadhyay, S., Mandal, S., Ghorai, M., Jha, N. K., Kumar, M., Radha, Ghosh, A., Proćków, J., Pérez de la Lastra, J. M., & Dey, A. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17635 · Cited by 220
Depressive disorders: treatment failures and poor prognosis over the last 50 years
Blackburn, T. P. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.472 · Cited by 136
Wang, L., Guo, T., Guo, Y., & Xu, Y. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11305 · Cited by 70
High Vitamin C Status Is Associated with Elevated Mood in Male Tertiary Students
Pullar, J., Carr, A., Bozonet, S., & Vissers, M. (2018) · Antioxidants · doi:10.3390/antiox7070091 · Cited by 52
Metadata
- Authors
- Jeon, S. W., & Kim, Y.-K.
- Venue
- Journal of Inflammation Research
- Publisher
- Informa UK Limited
- Published
- 2018-05
- Volume
- Volume 11
- Pages
- 179-192
- ISSN
- 1178-7031 (ISSN-L)
- OpenAlex
- W2802824384
- Cited by
- 118
- References
- 67
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.